Wednesday, Standard BioTools Inc. (LAB) announced a collaboration agreement with Navignostics AG to develop clinical research applications and service offerings using the Hyperion XTi Imaging System to combat cancer.
As part of the agreement, Standard BioTools will assist in the development of Navignostics assays by working together on various aspects of protocols and instrument and software features.
Moreover, both Navignostics and Standard BioTools intend to share their knowledge to advance the field of Imaging Mass Cytometry through co-publishing and presenting at scientific conferences in the upcoming year.
This collaboration highlights the importance of precision medicine strategies and robust technologies that provide essential biological insights to inform treatment decisions.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.